JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 2, 2006; DOI: 10.1124/jpet.105.097709


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.097709v1
317/2/522    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mak, I. T.
Right arrow Articles by Weglicki, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mak, I. T.
Right arrow Articles by Weglicki, W. B.


Received for publication October 26, 2005.
Revised February 1, 2006.
Accepted for publication February 1, 2006.

D-Propranolol Attenuates Lysosomal Iron Accumulation and Oxidative Injury in Endothelial Cells

I. Tong Mak 1*, Joanna Chmielinska 1, Lucie Nedelec 1, Armida Torres 1, William B. Weglicki 1

1 George Washington University

* Address correspondence to: E-mail: itmak{at}gwu.edu

Abstract

The influence of selected {beta}-receptor blockers on iron (Fe) overload and oxidative stress in endothelial cells (EC) was assessed. Confluent bovine EC were loaded with Fe-dextran (15 µM) for 24 hrs and then exposed to dihydroxyfumarate (DHF), a source of reactive oxygen species, for up to 2 hrs. Intracellular oxidant formation, monitored by fluorescence of 2'7' dichlorofluorescin (DCF, 30 µM), increased and peaked at 30 min; total glutathione decreased by 52±5% (p<0.01) at 60 min. When the EC were pre-treated 30 min before Fe loading with 1.25-10 µM d-propranolol, glutathione losses were attenuated 15-80% with EC50 =3.1 µM.. D-Propranolol partially inhibited the DCF intensity increase, but atenolol up to 10 µM was ineffective. At 2 hrs, caspase 3 activity was elevated 3.2±0.3-fold (p<0.01) in the Fe-loaded and DHF-treated EC, and cell survival determined 24 hrs later, decreased 47±6% (p<0.01). Ten µM d-propranolol suppressed the caspase 3 activation by 63% (p<0.05), and preserved cell survival back to 88% of control (p<0.01). In separate experiments, 24 hr Fe-loading resulted in a 3.6±0.8-fold increase in total EC Fe determined by atomic absorption spectroscopy; d-propranolol at 5 µM reduced this increase to 1.5±0.4-fold (p<0.01) of controls. Microscopic observation by Perls' staining revealed that the excessive iron accumulated in vesicular endosomal/lysosomal structures which were substantially diminished by d-propranolol. We previously showed that propranolol could readily concentrate into the lysosomes and raise the intra-lysosomal pH; it is suggested that this lysosomotropic properties of d-propranolol retarded the EC Fe accumulation, and thereby conferred the protective effects against Fe-load-mediated cytotoxicity.


Key words: D-propranolol, Endothelial cells, Iron-overload, Lysosomal iron, Lysosomotropic, Oxidative stress





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.